Yet, when someone with B12 deficiency reports that symptoms re-occur 4-5 weeks after a B12 injection, and wants to inject more often, all of a sudden, this person is mislabelled as suffering from the placebo effect of B12 injections
FDA compounding review On December 4, 2024, the FDA Pharmacy Compounding Advisory Committee (PCAC) reviewed AOD-9604 (free base) and AOD-9604 acetate against the 503A Bulks List
The other three are chemically identical to the vitamin B12 thats found in foods
AOD-9604 is currently sold for research purposes only and lacks regulatory approval from any major health authority worldwide
In fact, I don't just have one friend like this
p -values 0 and the presence of concomitant features of TCMR), and the presence of Q4-GSTTAb (Table 8)